Palbociclib in the Treatment of HR+/ HER2- Advanced or Metastatic Breast Cancer in Australia: A Real-World Retrospective Analysis
{{output}}
Background: There is limited real-world data on the use of CDK4/6 inhibitors in Australian patients with HR+/HER2- advanced or metastatic breast cancer. This study describes the demographic and clinical characteristics of patient... ...
